List of Concert Pharmaceuticals patents

Patents where

Current Assignee

Name

Concert Pharmaceuticals

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7678914 Deuterated benzo[	Patent 7678914 was granted and assigned to Concert Pharmaceuticals on March, 2010 by the United States Patent and Trademark Office.		Concert Pharmaceuticals	United States Patent and Trademark Office	7678914	March 16, 2010
‌ US Patent 8461197 4-hydroxybutyric acid analogs	Patent 8461197 was granted and assigned to Concert Pharmaceuticals on June, 2013 by the United States Patent and Trademark Office.		Concert Pharmaceuticals	United States Patent and Trademark Office	8461197	June 11, 2013
‌ US Patent 8987442 Deuterium-substituted xanthine derivatives and methods of use	Patent 8987442 was granted and assigned to Concert Pharmaceuticals on March, 2015 by the United States Patent and Trademark Office.		Concert Pharmaceuticals	United States Patent and Trademark Office	8987442	March 24, 2015
‌ US Patent 10040748 4-hydroxybutyric acid analogs	Patent 10040748 was granted and assigned to Concert Pharmaceuticals on August, 2018 by the United States Patent and Trademark Office.	Concert Pharmaceuticals	Concert Pharmaceuticals	United States Patent and Trademark Office	10040748	August 7, 2018
‌ US Patent 9051261 4-hydroxybutyric acid analogs	Patent 9051261 was granted and assigned to Concert Pharmaceuticals on June, 2015 by the United States Patent and Trademark Office.		Concert Pharmaceuticals	United States Patent and Trademark Office	9051261	June 9, 2015
‌ US Patent 9309182 4-hydroxybutyric acid analogs	Patent 9309182 was granted and assigned to Concert Pharmaceuticals on April, 2016 by the United States Patent and Trademark Office.	Concert Pharmaceuticals	Concert Pharmaceuticals	United States Patent and Trademark Office	9309182	April 12, 2016
‌ US Patent 8188110 Morphinan compounds	Patent 8188110 was granted and assigned to Concert Pharmaceuticals on May, 2012 by the United States Patent and Trademark Office.		Concert Pharmaceuticals	United States Patent and Trademark Office	8188110	May 29, 2012
‌ US Patent 7973049 Morphinan compounds	Patent 7973049 was granted and assigned to Concert Pharmaceuticals on July, 2011 by the United States Patent and Trademark Office.		Concert Pharmaceuticals	United States Patent and Trademark Office	7973049	July 5, 2011
‌ US Patent 10561659 Treatment of hair loss disorders with deuterated JAK inhibitors	Patent 10561659 was granted and assigned to Concert Pharmaceuticals on February, 2020 by the United States Patent and Trademark Office.	Concert Pharmaceuticals	Concert Pharmaceuticals	United States Patent and Trademark Office	10561659	February 18, 2020
‌ US Patent 9815763 4-hydroxybutyric acid analogs	Patent 9815763 was granted and assigned to Concert Pharmaceuticals on November, 2017 by the United States Patent and Trademark Office.	Concert Pharmaceuticals	Concert Pharmaceuticals	United States Patent and Trademark Office	9815763	November 14, 2017
‌ US Patent 11161798 4-hydroxybutyric acid analogs	Patent 11161798 was granted and assigned to Concert Pharmaceuticals on November, 2021 by the United States Patent and Trademark Office.	Concert Pharmaceuticals	Concert Pharmaceuticals	United States Patent and Trademark Office	11161798	November 2, 2021
‌ US Patent 7820666 Tetrahydrotriazolopyrazine derivatives and uses thereof	Patent 7820666 was granted and assigned to Concert Pharmaceuticals on October, 2010 by the United States Patent and Trademark Office.		Concert Pharmaceuticals	United States Patent and Trademark Office	7820666	October 26, 2010
‌ US Patent 10532971 4-hydroxybutyric acid analogs	Patent 10532971 was granted and assigned to Concert Pharmaceuticals on January, 2020 by the United States Patent and Trademark Office.	Concert Pharmaceuticals	Concert Pharmaceuticals	United States Patent and Trademark Office	10532971	January 14, 2020
‌ US Patent 7528131 Substituted morpholinyl compounds	Patent 7528131 was granted and assigned to Concert Pharmaceuticals on May, 2009 by the United States Patent and Trademark Office.		Concert Pharmaceuticals	United States Patent and Trademark Office	7528131	May 5, 2009
‌ US Patent 11473123 Morphinan compounds	Patent 11473123 was granted and assigned to Concert Pharmaceuticals on October, 2022 by the United States Patent and Trademark Office.	Concert Pharmaceuticals	Concert Pharmaceuticals	United States Patent and Trademark Office	11473123	October 18, 2022
‌ US Patent 9133137 Derivatives of gefitinib	Patent 9133137 was granted and assigned to Concert Pharmaceuticals on September, 2015 by the United States Patent and Trademark Office.		Concert Pharmaceuticals	United States Patent and Trademark Office	9133137	September 15, 2015
‌ US Patent 8759394 4-hydroxybutyric acid analogs	Patent 8759394 was granted and assigned to Concert Pharmaceuticals on June, 2014 by the United States Patent and Trademark Office.		Concert Pharmaceuticals	United States Patent and Trademark Office	8759394	June 24, 2014
‌ US Patent 9249149 Deuterated derivatives of ruxolitinib	Patent 9249149 was granted and assigned to Concert Pharmaceuticals on February, 2016 by the United States Patent and Trademark Office.	Concert Pharmaceuticals	Concert Pharmaceuticals	United States Patent and Trademark Office	9249149	February 2, 2016
‌ US Patent 9540367 Deuterated baricitinib	Patent 9540367 was granted and assigned to Concert Pharmaceuticals on January, 2017 by the United States Patent and Trademark Office.	Concert Pharmaceuticals	Concert Pharmaceuticals	United States Patent and Trademark Office	9540367	January 10, 2017
‌ US Patent 7863274 Deuterium enriched analogues of tadalafil as PDE5 inhibitors	Patent 7863274 was granted and assigned to Concert Pharmaceuticals on January, 2011 by the United States Patent and Trademark Office.		Concert Pharmaceuticals	United States Patent and Trademark Office	7863274	January 4, 2011
‌ US Patent 9512079 Deuterated CFTR potentiators	Patent 9512079 was granted and assigned to Concert Pharmaceuticals on December, 2016 by the United States Patent and Trademark Office.	Concert Pharmaceuticals	Concert Pharmaceuticals	United States Patent and Trademark Office	9512079	December 6, 2016
‌ US Patent 9181192 Deuterated CFTR potentiators	Patent 9181192 was granted and assigned to Concert Pharmaceuticals on November, 2015 by the United States Patent and Trademark Office.	Concert Pharmaceuticals	Concert Pharmaceuticals	United States Patent and Trademark Office	9181192	November 10, 2015
‌ US Patent 9707218 Derivatives of pyrazole-substituted amino-heteroaryl compounds	Patent 9707218 was granted and assigned to Concert Pharmaceuticals on July, 2017 by the United States Patent and Trademark Office.	Concert Pharmaceuticals	Concert Pharmaceuticals	United States Patent and Trademark Office	9707218	July 18, 2017
‌ US Patent 9074233 Process for preparing an enantiomerically enriched, deuterated secondary alcohol from a corresponding ketone without reducing deuterium incorporation	Patent 9074233 was granted and assigned to Concert Pharmaceuticals on July, 2015 by the United States Patent and Trademark Office.		Concert Pharmaceuticals	United States Patent and Trademark Office	9074233	July 7, 2015
‌ US Patent 9273009 Tetrahydronaphthalene derivatives	Patent 9273009 was granted and assigned to Concert Pharmaceuticals on March, 2016 by the United States Patent and Trademark Office.	Concert Pharmaceuticals	Concert Pharmaceuticals	United States Patent and Trademark Office	9273009	March 1, 2016

...

Results per page:

132 results

0 selected

132 results

0 selected